VITA 34 AG: Supervisory Board appoints Dr. André Gerth as CEO
VITA 34 AG / Key word(s): Change of Personnel 16.07.2012 19:02 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- VITA 34 AG: Supervisory Board appoints Dr. André Gerth as CEO Leipzig, July 16, 2012 - The Supervisory Board of VITA 34 AG (ISIN DE000A0BL849), the oldest private umbilical cord blood bank in the German-speaking countries, appointed Dr. André Gerth as CEO with immediate effect. The 48-year-old has been a member of the company's Management Board since the beginning of June 2012 and has been responsible for the operational business and foreign activities since then. Press/ Investor Relations: Axel Mühlhaus Peggy Kropmanns edicto GmbH Eschersheimer Landstr. 42-44 60322 Frankfurt Phone:+49 (069) 90550550 Fax: +49 (069) 90550577 E-Mail: vita34@edicto.de 16.07.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: VITA 34 AG Deutscher Platz 5a 04103 Leipzig Germany Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: info@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------